Avid Bioservices Inc (CDMO)

[PPHMVERYLONG]

Wall Street is well aware of this list and has discounted them for the same reasons I have that are listed below:


1) Completing enrollment will do nothing. First interim look-in will say no more than the trial is to continue.


2) Avid expansion - will not significantly effect the bottom for some time,if ever. Will never be significant unless it brings in ten of millions a year in positive cash flow.


3) Bavi-Yervoy trial - a Phase I trial, enough said.



4) Research with MSK starting up - yes starting up, results will not be known for years.


5) New trials in breast cancer and with Opdivo. New trials, that means many years before results are known.